Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00691262
Recruitment Status : Completed
First Posted : June 5, 2008
Last Update Posted : September 1, 2014
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2005
  Study Completion Date : February 2005